Want to join the conversation?
Biopharmaceutical services company $PRXL said that it has agreed to acquire all outstanding equity securities of Health Advances, LLC, a life sciences consulting firm. The acquisition is expected to close in Feb., subject to closing conditions including expiration or termination of waiting period under the Hart-Scott-Rodino Act.
Still in yesterday’s $PZZA shock. I thought everyone had more pizza this football season!!
$TSLA stock downgraded to sell from hold by brokerage firm CFRA Research. However, the firm lifted the price target by $35 to $240.
$LB shares have plummeted after a disappointing quarter.